Directory
>
Chris Lay
Chris Lay
Vice President, Global Market Analytics | Array BioPharma Inc.
Denver, Colorado, United States
Chris Lay
Summary
Chris Lay is a seasoned Vice President specializing in Global Market Analytics within the pharmaceuticals industry. With a robust background in biopharmaceuticals and biotechnology, he has led cross-functional teams to drive strategic planning and market access initiatives. His extensive experience spans over two decades, with significant roles at renowned organizations such as Array Biopharma and Genentech. Chris has a proven track record in business development, competitive intelligence, and commercialization strategies, particularly in cardiology and oncology. He holds an MBA from Duke University and a BA in Economics from the University of California, Santa Cruz. Known for his analytical prowess and leadership skills, Chris has built and guided high-performing teams, contributing to the successful launch of multiple pharmaceutical products. Outside of work, he is passionate about mentoring emerging leaders in the life sciences sector.
Chris Lay
Work Experience
Vice President, Global Market Analytics at
Array BioPharma Inc.
August 2017 - Present
Executive Director, Global Business Analytics at
Array BioPharma Inc.
May 2015 - August 2017
Executive Director, Global Business Analytics at
Sunesis Pharmaceuticals, Inc.
August 2014 - May 2015
Senior Executive Director, Business Analytics at
Pharmacyclics, an AbbVie Company
March 2013 - August 2014
Executive Director, Business Analytics at
AFFYMAX LIMITED
May 2011 - March 2013
Associate Director, Market Planning at
Genentech Foundation
September 2009 - May 2011
Group Market Planning Manager at
Genentech Foundation
January 2008 - September 2009
Director, Business Analysis and Information at
Amgen, Inc.
August 2002 - January 2008
Director, Global Marketing Information at
AbbVie
January 2001 - August 2002
Senior Manager – Market Analytics, New Product Development at
Pfizer, Inc.
April 1999 - January 2001
Senior Manager - Marketing Analysis and New Product Planning at
Merck
June 1994 - April 1999
Chris Lay
Education
Duke University - The Fuqua School of Business, Mba
January 1992 - January 1994
University of California Santa Cruz, Ba
January 1985 - January 1989
Frequently Asked Questions about Chris Lay
What is Chris Lay email address?
Chris Lay's primary email address is *********@allergan.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Chris Lay work for?
Chris Lay is a Vice President, Global Market Analytics at Array BioPharma Inc., a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Chris Lay graduated from?
Chris Lay holds a degree in Marketing from Duke University - The Fuqua School of Business.
How can I directly contact Chris Lay?
To contact Chris Lay directly, you can use the email address *********@allergan.com. Complete contact information is available upon registration with Muraena.
Who is Chris Lay?
Chris Lay is a seasoned Vice President specializing in Global Market Analytics within the pharmaceuticals industry. With a robust background in biopharmaceuticals and biotechnology, he has led cross-functional teams to drive strategic planning and market access initiatives. His extensive experience spans over two decades, with significant roles at renowned organizations such as Array Biopharma and Genentech. Chris has a proven track record in business development, competitive intelligence, and commercialization strategies, particularly in cardiology and oncology. He holds an MBA from Duke University and a BA in Economics from the University of California, Santa Cruz. Known for his analytical prowess and leadership skills, Chris has built and guided high-performing teams, contributing to the successful launch of multiple pharmaceutical products. Outside of work, he is passionate about mentoring emerging leaders in the life sciences sector.
Chris`s contact details
*********@allergan.com
*********@arraybiopharma.com
Colleagues
VP Enzymology and Structural Biology
Chief Software Architect
Vice President